SeaStar Medical Holding Corporation Stock Analysis & AI Score
SeaStar Medical Holding Corporation (ICU) has an ST Score of 48.8 (C+), driven by its Growth (A+) and held back by its Profitability (F). Analysts rate it Buy with a $8.00 price target (+132.6% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
SeaStar Medical Holding Corporation (ICU) has an ST Score of 48.8 (C+), driven by its Growth (A+) and held back by its Profitability (F). Analysts rate it Buy with a $8.00 price target (+132.6% upside).
- Strongest
- GrowthA+
- Weakest
- ProfitabilityF
All factor grades
- GrowthA+
- ForecastA
- MomentumA-
- Financial StrengthC
- ValuationD+
- ProfitabilityF
- Piotroski2/9
Contact
ICU stock: frequently asked questions
What is ICU's ST Score?
SeaStar Medical Holding Corporation (ICU) has an ST Score of 48.8 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ICU a buy, hold, or sell?
Analysts rate ICU a Buy, with a price target of $8.00 (+132.6% vs the current price). Our ST Score grades it C+ (48.8/100). The ST Score is a data-driven signal, not a recommendation.
What are ICU's factor grades?
Valuation D+, Profitability F, Financial Strength C, Momentum A-, Growth A+, Forecast A.
What is ICU's valuation grade?
SeaStar Medical Holding Corporation (ICU) earns a valuation grade of D+, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ICU's growth grade?
SeaStar Medical Holding Corporation (ICU) earns a growth grade of A+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ICU's profitability grade?
SeaStar Medical Holding Corporation (ICU) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ICU's financial strength grade?
SeaStar Medical Holding Corporation (ICU) earns a financial strength grade of C, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for ICU?
The average analyst price target for SeaStar Medical Holding Corporation (ICU) is $8.00 from 1 analysts, which is +132.6% versus the recent price of $3.44.
What is ICU's Piotroski score?
SeaStar Medical Holding Corporation (ICU) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.